Research Calls I
-
Upgrades:
- Carnival (CCL) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $31
- Cross Country (CCRN) upgraded to Outperform from Neutral at Wedbush; tgt $15
- Five Below (FIVE) upgraded to Outperform from Market Perform at William Blair
- Fluence Energy (FLNC) upgraded to Neutral from Sell at Guggenheim
- Mastercard (MA) upgraded to Outperform from Neutral at BNP Paribas Exane, tgt $600
- MoonLake Immunotherapeutics (MLTX) upgraded to Buy from Neutral at Rothschild & Co Redburn, tgt $40
- Nu Holdings (NU) upgraded to Buy from Neutral at UBS, tgt $17.60
- South State (SSB) upgraded to Outperform from Market Perform at Hovde Group, tgt $110
- Tandem Diabetes Care (TNDM) upgraded to Buy from Hold at Truist, tgt $35
- Union Pacific (UNP) upgraded to Outperform from In Line at Evercore ISI, tgt $262
- Carnival (CCL) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $31
-
Downgrades:
- CSX (CSX) downgraded to In Line from Outperform at Evercore ISI, tgt $41
- Freshworks (FRSH) downgraded to Perform from Outperform at Oppenheimer
- Kinsale Capital (KNSL) downgraded to Underperform from Hold at Jefferies, tgt $312
- Life360 (LIF) downgraded to Neutral from Buy at DA Davidson, tgt $40
- Micron (MU) downgraded to Hold from Buy at Summit Insights
- Xponential Fitness (XPOF) downgraded to Market Perform from Strong Buy at Raymond James
- CSX (CSX) downgraded to In Line from Outperform at Evercore ISI, tgt $41
-
Others:
- ADP (ADP) initiated with a Buy at Guggenheim, tgt $270
- ALX Oncology (ALXO) initiated with an Overweight at Wells Fargo, tgt $5
- Aligos Therapeutics (ALGS) assumed with a Buy at Jefferies, tgt $48
- EnerSys (ENS) initiated with a Buy at TD Cowen, tgt $190
- FrontView REIT (FVR) initiated with a Buy at B. Riley, tgt $20.50
- Globe Life (GL) initiated with a Buy at Texas Capital Securities, tgt $170
- Inventiva (IVA) initiated with a Buy at Truist, tgt $13
- MapLight Therapeutics (MPLT) initiated with a Buy at Canaccord, tgt $35
- Okta (OKTA) initiated with an Outperform at Macquarie, tgt $100
- Olema Pharmaceuticals (OLMA) assumed with a Buy at Jefferies
- Paychex (PAYX) initiated with a Neutral at Guggenheim
- Rocket Lab USA (RKLB) initiated with a Buy at Clear Street, tgt $88
- Saneamento Basico (SBS) initiated with a Buy at Jefferies, tgt $36.60
- Slide Insurance Holdings (SLDE) initiated with a Buy at Texas Capital, tgt $25
- SoFi Technologies (SOFI) initiated with an Equal Weight at Wells Fargo, tgt $19
- Vor Biopharma (VOR) initiated with an Overweight at Wells Fargo, tgt $30
- ADP (ADP) initiated with a Buy at Guggenheim, tgt $270